Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Dried blood spot (DBS) samples were collected during spring of 2020 from random and undiagnosed individuals in Stockholm, Sweden. <div><br></div><div>Receiving DBS from 878 participants, we applied multiplexed serology assays to determine IgG and IgM levels against several versions of SARS-CoV-2 proteins (S, RBD, N).</div><div><br></div><div>The data reports anonymised an normalised "relative antibody titers" obtained in the eluates of the DBS samples. The data can be made available for validation purposes and upon reasonable request. </div><div><div><br></div><div>A reasonable request should contain:</div><div>1) Name of PI and host organisation</div><div>2) Contact details</div><div>3) Scientific purpose of data access request</div><div>4) Commitment to inform when the data has been used in a publication</div><div>5) Commitment not to host or share the data outside the requesting organisation</div><div>6) Statement of non-commercial use of data</div></div>